Markets

CSL Vifor and Travere Therapeutics acknowledge the updated KDIGO 2025 guidelines for IgA Nephropathy (IgAN). These guidelines refine diagnostic criteria, treatment goals, and therapeutic approaches for this leading cause of kidney failure. Notably, FILSPARI® (sparsentan), a Dual Endothelin Angiotensin Receptor Antagonist (DEARA), is highlighted as a potential first-line treatment option for managing IgAN-induced nephron loss, contrasting the traditional RASi-first approach. The guidelines cite the PROTECT trial, demonstrating FILSPARI’s efficacy compared to optimized RASi therapy. Experts believe the updated guidance will improve treatment decisions and long-term kidney outcomes.

Mirion Technologies (NYSE: MIR) announced the pricing of an upsized public offering of 17.3 million shares of Class A common stock at $21.35 per share, aiming to raise approximately $356.2 million. Simultaneously, they priced a $325 million convertible senior notes offering. Proceeds will fund capped call transactions related to the notes and the acquisition of Paragon Energy Solutions. The offerings are expected to close on September 30, 2025. Goldman Sachs and Evercore ISI are leading the common stock offering. These moves support Mirion’s growth strategy in radiation safety, science, and medicine.

CenterPoint Energy (CNP) declared a regular quarterly cash dividend of $0.2200 per share, payable December 11, 2025, to shareholders of record on November 20, 2025. Analysts view the consistent dividend as a sign of financial health amidst industry transformation. While reassuring to investors, the company faces challenges related to renewable energy integration, grid modernization, and capital expenditures. CenterPoint’s long-term success hinges on its ability to execute modernization plans, maintain operational efficiency, and adapt to evolving customer demands across its multi-state service territories.

Wellgistics Health (WGRX) announced a $5 million public offering of 7,142,862 shares and warrants priced at $0.70 per share. Warrants are exercisable at $0.70 immediately and expire in five years. The offering, managed by H.C. Wainwright & Co., is expected to close around September 29, 2025. Proceeds will fund working capital, operating expenses, R&D, and potential acquisitions. The offering entails significant shareholder dilution.

Lytus Technologies (LYTHF) announced a 1-for-2,500 reverse stock split, effective September 26, 2025, aiming to increase its market price to meet NYSE American listing requirements. The company will continue trading under “LYTHF” with CUSIP number G5851A141. The split impacts all shareholders uniformly, rounding fractional shares up. VStock Transfer LLC is the transfer agent. The company focuses on platform services, including streaming, telemedicine, and fintech across India and international markets.

Paramount Skydance Corporation (PSKY) has appointed Makan Delrahim as Chief Legal Officer, effective October 6, 2025. Delrahim, formerly a Partner at Latham & Watkins and Assistant Attorney General overseeing the Antitrust Division, will lead Paramount’s legal, regulatory, and public policy initiatives. This strategic hire signals Paramount’s focus on navigating the evolving regulatory landscape and complex issues related to digital disruption and content monetization. David Ellison, Chairman and CEO, emphasized Delrahim’s unique perspective and experience as vital for Paramount’s future.

On September 25, 2025, Freddie Mac (FMCC) announced an auction of approximately $487 million in non-performing residential first lien whole loans. The sale includes four Standard Pool Offerings (SPO) and one Extended Timeline Pool Offering (EXPO), targeting different investor sizes. Bids are due October 16 (SPO) and October 30 (EXPO). The move aims to reduce less-liquid assets. Since 2011, Freddie Mac has sold $10.7 billion in NPLs.

Global Helium Corp. (HECO) is set to hold a shareholder vote on October 16, 2025, regarding a proposed acquisition by 2679158 Alberta Ltd. The arrangement requires a 66⅔% supermajority approval and a simple majority from minority shareholders. Holders of 52.5% of shares have pledged support. The board, excluding a conflicted director, recommends approval. The transaction, expected to close around October 24, 2025, is subject to standard closing conditions, including court and regulatory approvals. A special committee conducted a review of the proposed transaction.

The International Insurance Society (IIS) announced the finalists for the 2025 RGA Leaders of Tomorrow Award. These emerging leaders were selected for their research addressing key challenges in insurance and risk management. Finalists include Robin Huettemann (McKinsey), focusing on public-private partnerships for natural catastrophe resilience; Sulim Lee (AIA), exploring the role of human advisors in the age of AI; and Anne-Katherin Schirlitz (Gallagher Re), examining growth imperatives in reinsurance. They will present their research at the IIS Global Insurance Forum in Switzerland, where the 2025 RGA Leader of Tomorrow will be named.

AGCO will showcase “Farmer-First” innovations at its annual Tech Day in Markt Indersdorf, Germany, September 30-October 1, 2025. The event highlights precision ag solutions from PTx™ and other brands like Fendt, Massey Ferguson, and Valtra, focusing on integrated farm management, autonomous technology, and automated harvesting and planting. AGCO aims to deliver solutions compatible with mixed fleets, improve yields, and reach $2 billion in precision ag sales by 2029. Technologies include PTx FarmENGAGE, autonomous tillage/fertilizing, and AI-based weed control.